Skip to main content
ConductScienceScienceDex
NIH funding notice RFA-NS-20-028

HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)

Closed on June 24, 2020.

Posted
January 21, 2020
Close date
June 24, 2020
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

1 competing award (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $523,335 in first-year total cost, median $523,335.

Most frequent study sections

  1. Special Emphasis Panel[ZRG1 ETTN-T (50)]1

Most frequent institutions

  1. NEW YORK UNIVERSITY SCHOOL OF MEDICINE1
Competing awards under RFA-NS-20-028 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2020Optimizing the use of ketamine to reduce chronic postsurgical pain1UG3CA261067-01DOAN, LISAWANG, JINGNEW YORK UNIVERSITY SCHOOL OF MEDICINE, NY$523,335ZRG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

Start your CVHow the NIH biosketch works
RFA-NS-20-028: HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required) | ScienceDex | ConductScience